{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T03:01:04Z","timestamp":1761102064326},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.cca.2013.04.022","type":"journal-article","created":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T14:49:26Z","timestamp":1367333366000},"page":"66-68","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Idursulfase enzyme replacement therapy in an adult patient with severe Hunter syndrome having a novel mutation of iduronate-2-sulfatase gene"],"prefix":"10.1016","volume":"423","author":[{"given":"Antonius","family":"Christianto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Inazu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2013.04.022_bb0005","series-title":"The metabolic and molecular bases of inherited disease","first-page":"2465","article-title":"The mucopolysaccharidoses","author":"Neufeld","year":"1995"},{"issue":"1","key":"10.1016\/j.cca.2013.04.022_bb0010","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ymgme.2009.08.006","article-title":"Japan Elaprase Treatment (JET) study: idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis II, MPS II)","volume":"99","author":"Okuyama","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.cca.2013.04.022_bb0015","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1111\/j.1468-3083.2007.02203.x","article-title":"Natural history of extensive Mongolian spots in Mucopolysaccharidosis type II (Hunter syndrome): a survey among 52 Japanese patients","volume":"21","author":"Ochiai","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.cca.2013.04.022_bb0020","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/humu.9128","article-title":"Mutational spectrum of the iduronate 2 sulfatase gene in 25 unrelated Korean Hunter syndrome patients: identification of 13 novel mutations","volume":"21","author":"Kim","year":"2003","journal-title":"Hum Mutat"},{"issue":"8","key":"10.1016\/j.cca.2013.04.022_bb0025","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10038-005-0266-4","article-title":"Mutational and structural analysis of Japanese patients with mucopolysaccharidosis type II","volume":"50","author":"Kato","year":"2005","journal-title":"J Hum Genet"},{"issue":"1","key":"10.1016\/j.cca.2013.04.022_bb0030","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cca.2006.01.001","article-title":"Detection of Hunter syndrome (mucopolysaccharidosis type II) in Taiwanese: biochemical and linkage studies of the iduronate-2-sulfatase gene defects in MPS II patients and carriers","volume":"369","author":"Lin","year":"2006","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.cca.2013.04.022_bb0035","first-page":"253","article-title":"Long-term enzyme replacement therapy in a severe case of mucopolysaccharidosis type II (Hunter syndrome)","volume":"15","author":"Papadia","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.cca.2013.04.022_bb0040","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1006\/geno.1993.1406","article-title":"Sequence of the human iduronate 2-sulfatase (IDS) gene","volume":"17","author":"Wilson","year":"1993","journal-title":"Genomics"},{"key":"10.1016\/j.cca.2013.04.022_bb0130","doi-asserted-by":"crossref","first-page":"8531","DOI":"10.1073\/pnas.87.21.8531","article-title":"Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA","volume":"87","author":"Wilson","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cca.2013.04.022_bb0050","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1651-2227.2002.tb03118.x","article-title":"Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report","volume":"91","author":"Muenzer","year":"2002","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/j.cca.2013.04.022_bb0055","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ymgme.2006.09.001","article-title":"A phase I\/II clinical trial of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2007","journal-title":"Mol Genet Metab"},{"issue":"6","key":"10.1016\/j.cca.2013.04.022_bb0060","first-page":"1202","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): mutation \u201chot spots\u201d in the iduronate-2-sulfatase gene","volume":"59","author":"Rathmann","year":"1996","journal-title":"Am J Hum Genet"},{"issue":"1\u20132","key":"10.1016\/j.cca.2013.04.022_bb0065","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cca.2008.02.009","article-title":"Molecular investigations of a novel iduronate-2-sulfatase mutant in a Chinese patient","volume":"392","author":"Lau","year":"2008","journal-title":"Clin Chim Acta"},{"issue":"3","key":"10.1016\/j.cca.2013.04.022_bb0070","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1136\/adc.79.3.237","article-title":"Mutation analysis in 57 unrelated patients with MPS II (Hunter's disease)","volume":"79","author":"Vafiadaki","year":"1998","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.cca.2013.04.022_bb0075","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ymgme.2003.11.002","article-title":"Iduronate-2-sulphatase protein detection in plasma from mucopolysaccharidosis type II patients","volume":"81","author":"Parkinson","year":"2004","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.cca.2013.04.022_bb0080","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/bj3260243","article-title":"Characterization of iduronate sulphatase mutants affecting N-glycosylation sites and the cystein-84 residue","volume":"326","author":"Millat","year":"1997","journal-title":"Biochem J"},{"issue":"4","key":"10.1016\/j.cca.2013.04.022_bb0085","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/dna.1995.14.305","article-title":"Intracellular sorting of aspartylglucosaminidase: the role of N-linked oligosaccharides and evidence of Man-6-P-independent lysosomal targeting","volume":"14","author":"Tikkanen","year":"1995","journal-title":"DNA Cell Biol"},{"issue":"2\u20133","key":"10.1016\/j.cca.2013.04.022_bb0090","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0925-4439(00)00006-5","article-title":"Expression of five iduronate-2-sulfatase site directed mutations","volume":"1501","author":"Villani","year":"2000","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"10.1016\/j.cca.2013.04.022_bb0095","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/01.gim.0000232477.37660.fb","article-title":"A phase II\/III clinical study of enzyme replacement therapy with idursulfase in mucopolysaccharidosis II (Hunter syndrome)","volume":"8","author":"Muenzer","year":"2006","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.cca.2013.04.022_bb0100","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00431-007-0635-4","article-title":"Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy","volume":"167","author":"Wraith","year":"2007","journal-title":"Eur J Pediatr"},{"issue":"2","key":"10.1016\/j.cca.2013.04.022_bb0105","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/GIM.0b013e3181fea459","article-title":"Long-term, open-labeled extension study of idursulfase in the treatment of Hunter syndrome","volume":"13","author":"Muenzer","year":"2011","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.cca.2013.04.022_bb0110","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s10545-009-1119-7","article-title":"Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter Outcome Survey (HOS)","volume":"32","author":"Jones","year":"2009","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.cca.2013.04.022_bb0115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pediatrneurol.2011.05.010","article-title":"Hunter disease before and during enzyme replacement therapy","volume":"45","author":"Hoffmann","year":"2011","journal-title":"Pediatr Neurol"},{"issue":"1","key":"10.1016\/j.cca.2013.04.022_bb0120","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00431-011-1606-3","article-title":"The role of enzyme replacement therapy in severe Hunter syndrome-an expert panel consensus","volume":"171","author":"Muenzer","year":"2012","journal-title":"Eur J Pediatr"},{"issue":"3","key":"10.1016\/j.cca.2013.04.022_bb0125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.pediatrneurol.2012.01.006","article-title":"Idursulfatase therapy in mucopolysaccharidosis type II: after 2.5years of treatment\u2013no benefit for older patients with multisystem involvement","volume":"46","author":"Gucev","year":"2012","journal-title":"Pediatr Neurol"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811300185X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000989811300185X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T07:53:50Z","timestamp":1539676430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000989811300185X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":25,"alternative-id":["S000989811300185X"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2013.04.022","relation":{},"ISSN":["0009-8981"],"issn-type":[{"type":"print","value":"0009-8981"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Idursulfase enzyme replacement therapy in an adult patient with severe Hunter syndrome having a novel mutation of iduronate-2-sulfatase gene","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2013.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}